Todd Hutson

Todd Hutson is a seasoned professional with extensive experience in market access and reimbursement within the oncology sector. Currently serving as a National Account Executive at BioLineRx since April 2023, Todd has held significant roles at EMD Serono, Inc., and Eisai US, where responsibilities included managing field patient services and supporting government programs. Previously, Todd directed national reimbursement teams across multiple companies, including MGI Pharma and Amgen, focusing on Medicare, Medicaid, and commercial payer support for oncology products. Todd's career began at Lederle Laboratories as a Combination Sales Representative, and education includes a Bachelor of Science in Biology, Chemistry, and Business from Troy University.